paclitaxel,carboplatin,nivolumab
bms
['sclc', 'nadim 2', 'nadim', 'nsclc']
the #oncoalerttoptweet day 3 #asco22 tweet nadim 2 trial from presented by confirms superiority of neoadjuvant chemo-immunotherapy approach in st iiia #nsclc best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??